Lansing Street Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $43.1K | Hold |
60
| – | – | 0.03% | 144 |
|
|
2023
Q1 | $49.3K | Hold |
60
| – | – | 0.03% | 143 |
|
|
2022
Q4 | $43.3K | Hold |
60
| – | – | 0.03% | 161 |
|
|
2022
Q3 | $41K | Hold |
60
| – | – | 0.03% | 141 |
|
|
2022
Q2 | $35K | Hold |
60
| – | – | 0.03% | 142 |
|
|
2022
Q1 | $44K | Buy |
+60
| New | +$44K | 0.03% | 140 |
|